Metabolic dysfunction-associated fatty liver disease is now recognised as the most common chronic liver disease globally, ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

In adults with nonalcoholic fatty liver disease and obesity, the estimated glucose disposal rate strongly negatively correlated with liver fibrosis severity.

Researchers identified a rare variant on a single gene that appears to predispose patients to metabolic ...

A new study published in Science Advances reveals that a single gene plays a big role in how the liver stores energy, a ...

A new study reveals that a single gene plays a big role in how the liver stores energy, a process that's critical for overall health and for managing diseases like type 2 diabetes. The research ...

Over the decades, the causes and prevalence of fatty liver disease have undergone significant changes. From the 1940s to the 1990s, alcohol was widely recognise ...

Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) has demonstrated sustained efficacy in a late-stage trial of patients with ...

A new study reveals the shocking relationship between early-onset colorectal cancer and a super common disease that impacts ...

GSK has agreed to pay $1.2 billion upfront to acquire rights to efimosfermin from Cambridge, Massachusetts-based Boston ...

Liver fibrosis is a gradually worsening condition marked by excessive collagen buildup resulting from ongoing liver damage.

Altimmune's Q1 2025 earnings call highlights breakthroughs in NASH treatments, robust financials with a new $100M credit facility, and imminent Phase ...